Study of Disabling T-Cell Activation and Inhibiting T-Cell-Mediated Immunopathology Reveals a Possible Inverse Agonist Activity of CD4 Peptidomimetics

Author: Horie T.   Shen Y.   Kajino K.   Gaubin M.   Bonomi G.   Mani J-C.   Berezov A.   Piatier-Tonneau D.   Guardiola J.   Hillard B.   Rostami A.   Greene M.I.   Murali R.  

Publisher: Academic Press

ISSN: 0014-4800

Source: Experimental and Molecular Pathology, Vol.73, Iss.2, 2002-10, pp. : 93-103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract